)
PetMed Express (PETS) investor relations material
PetMed Express Q3 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Net sales for the quarter ended December 31, 2025, declined 21.7% year-over-year to $40.7 million, with a 22.7% decrease for the nine-month period to $136.2 million, primarily due to lower prescription medication sales and increased promotional activity.
Gross profit fell 41.4% to $9.5 million for the quarter, and 32.8% to $36.3 million for the nine months, with gross margin dropping to 23.3% from 31.0% year-over-year for the quarter.
The company recorded a net loss of $10.6 million for the quarter and $53.2 million for the nine months, compared to net losses of $0.7 million and net income of $5.4 million, respectively, in the prior year periods.
Adjusted EBITDA was negative $7.6 million for the quarter and negative $12.6 million for the nine months, reflecting significant operational and non-cash charges.
Financial highlights
Cost of sales as a percentage of sales increased to 76.7% for the quarter, up from 69.0% in the prior year, driven by a $2.1 million inventory write-down and higher promotional usage.
General and administrative expenses rose 13.1% to $12.2 million for the quarter and 50.3% to $39.3 million for the nine months, mainly due to higher stock-based compensation and professional fees related to an internal investigation.
Advertising expenses increased 26.7% to $5.3 million for the quarter but decreased 14.2% to $15.7 million for the nine months; customer acquisition cost rose to $90 per new customer for the quarter.
Depreciation and amortization expense was $2.4 million for the quarter and $7.0 million for the nine months.
Cash and cash equivalents decreased to $26.9 million at December 31, 2025, from $54.7 million at March 31, 2025.
Outlook and guidance
Management expects continued challenges from macroeconomic factors such as inflation, interest rates, and changing consumer behavior, which may impact future sales and profitability.
The company believes current cash and expected future cash flows are sufficient for at least the next twelve months, but longer-term liquidity depends on operational performance.
Next PetMed Express earnings date
Next PetMed Express earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)